Fischer Medical Ventures Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 5.87 | 0.87 | 0.82 |
| Operating Expense | 6.78 | 0.21 | 0.36 |
| Net Profit | -0.89 | 0.20 | 0.51 |
| Net Profit Margin | -15.16 | 22.99 | 62.20 |
| Earning Per Share | -0.06 | 0.04 | 0.10 |
| EBIDTA | -0.64 | 0.66 | 0.46 |
| Effective Tax Rate | -3.30 | 63.64 | -10.87 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 5.87 |
| Operating Expense | 6.78 |
| Net Profit | -0.89 |
| Net Profit Margin | -15.16 |
| Earning Per Share | -0.06 |
| EBIDTA | -0.64 |
| Effective Tax Rate | -3.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 11.53 | 0.18 | TBA |
| Operating Expenses Annual | 11.72 | 0.16 | 0.19 |
| Operating Profit Annual | 0.56 | 0.02 | -0.19 |
| Interest Annual | 0.02 | 0.02 | 0.01 |
| Depreciation | 0.00 | TBA | TBA |
| Net Profit Annual | 0.40 | -0.04 | -0.23 |
| Tax Annual | 0.14 | 0.04 | 0.04 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 11.53 |
| Operating Expenses Annual | 11.72 |
| Operating Profit Annual | 0.56 |
| Interest Annual | 0.02 |
| Depreciation | 0.00 |
| Net Profit Annual | 0.40 |
| Tax Annual | 0.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.04 | 0.02 | 0.04 |
| Cash Flow from Operations | 0.08 | -0.15 | -0.18 |
| Cash Flow from Investing | -37.78 | TBA | TBA |
| Cash Flow from Financing | 37.67 | 0.17 | 0.15 |
| Cash Flow at the End | TBA | 0.04 | 0.02 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.04 |
| Cash Flow from Operations | 0.08 |
| Cash Flow from Investing | -37.78 |
| Cash Flow from Financing | 37.67 |
| Cash Flow at the End | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 4.86 | 11.11 | TBA |
| PBIT Margin (%) | 4.86 | 11.11 | TBA |
| PBT Margin (%) | -237.98 | -544.45 | TBA |
| Net PROFIT Margin (%) | 3.47 | -22.22 | TBA |
| Return On Networth / Equity (%) | 1.01 | TBA | TBA |
| Return On Networth /Employed (%) | 1.40 | TBA | TBA |
| Return On Assets (%) | 1.01 | -17.11 | TBA |
| Total Debt / Equity (X) | 0.01 | TBA | TBA |
| Asset Turnover Ratio (%) | 0.29 | 0.77 | TBA |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 4.86 |
| PBIT Margin (%) | 4.86 |
| PBT Margin (%) | -237.98 |
| Net PROFIT Margin (%) | 3.47 |
| Return On Networth / Equity (%) | 1.01 |
| Return On Networth /Employed (%) | 1.40 |
| Return On Assets (%) | 1.01 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.29 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 0.01 | TBA | TBA |
| Total Current Assets Annual | 50.54 | 0.25 | 0.05 |
| Non Current Assets Annual | 41.29 | 0.11 | 0.14 |
| Total Shareholders Funds Annual | 79.68 | -0.27 | -0.23 |
| Total Assets Annual | 91.83 | 0.35 | 0.19 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 0.01 |
| Total Current Assets Annual | 50.54 |
| Non Current Assets Annual | 41.29 |
| Total Shareholders Funds Annual | 79.68 |
| Total Assets Annual | 91.83 |
EPS (INR)
Expected
0.28
Reported
0.09
Surprise
-67.86%
Dec 2024
EPS beaten by -67.86%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
